A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
about
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceHyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Arabidopsis AtPARK13, which confers thermotolerance, targets misfolded proteins.Unravelling the role of defective genes.Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1.Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's diseaseMitochondrial dysfunction in genetic animal models of Parkinson's diseasePathogenic variants in HTRA2 cause an early-onset mitochondrial syndrome associated with 3-methylglutaconic aciduria.Genetics of Parkinson disease and essential tremorMutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease.Mitochondrial protein quality control in health and disease.DNA methylation in neurodegenerative disorders: a missing link between genome and environment?Mitochondrial quality control: a matter of life and death for neurons.Mitochondrial Stress Signalling: HTRA2 and Parkinson's Disease.Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Parkinson's disease: from genetics to clinical practice.The role of FUS gene variants in neurodegenerative diseases.Mitochondrial Quality Control Proteases in Neuronal Welfare.Mutations in HTRA2 are not a common cause of familial classic ET.Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.Mitochondrial dysfunction in Parkinson's disease
P2860
Q28074143-8AED5B7A-4C4C-4D4D-BDCE-E73B8DF07367Q28478469-1ABABFF9-7CCD-4671-97F7-E958F63FF0B0Q30497725-708F28DE-C94E-443D-9FA8-089D9D4720CBQ33364885-44C2BF04-8379-4824-8C41-D21AC3C4C7C0Q33652004-37BCFE96-E9CF-41BB-BDE5-67A6AD568F80Q34201811-FA02BCB5-0531-4A91-A9CE-AC812B624CE0Q34758274-5909D0C1-A898-4F33-BA0C-9246010ABEC8Q35544534-04600A4B-410D-40AB-91CF-5D43AE219FC6Q35585384-CBAD1AD5-FCA5-4B46-94F8-33F28029091EQ35799109-DD0CC653-3345-4BB6-B302-079410D28B6AQ37547480-AB48C434-7A7F-4A72-A551-0ED90FA912FAQ37594762-55C5F6A4-CA02-461C-B5FF-D9C8C71C4A08Q37627534-1E4CD949-33ED-44D8-BEA1-72CB9BDF4B38Q37686252-0B07D72F-639E-4653-BEE9-2B3A76F289A8Q37872024-860A3F06-6DEF-4D88-8D0C-1C22433D58C5Q37987023-E2ECDDFB-F81A-47C4-8D5F-0E6951E3828CQ38016860-0B2B8D35-D58E-49F2-A566-5E481F7E8CF0Q38115298-7AC7A7E5-79E1-43C9-AA26-49A9B34E44ABQ38188556-3645284F-522D-4EF5-BF79-0DE82855383CQ38212812-652C928A-1090-4B05-834E-D2223E268EBFQ38823556-F8C1E1D7-FD3B-4491-A8B0-9887BEE36955Q50245099-1FAE401E-7B6A-46FC-A18B-887B8A103629Q55081064-9FC2FDE7-5875-4928-8CDB-4C4506CB071BQ58693945-9A1FC09A-4CAD-44FC-9514-90D82836501A
P2860
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@ast
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@en
type
label
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@ast
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@en
prefLabel
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@ast
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@en
P2093
P2860
P50
P1476
A large-scale genetic associat ...... ARK13) to Parkinson's disease.
@en
P2093
Alexis Elbaz
Ana Djarmati
Carlo Ferrarese
Demetrius M Maraganore
Eng King Tan
Francesa de Nigris
Genetic Epidemiology of Parkinson's disease consortium
Georgia Xiromerisiou
Georgios M Hadjigeorgiou
Grzegorz Opala
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2009.11.021
P50
P577
2009-12-24T00:00:00Z